CACLP - The largest IVD Expo & Conference

Seegene Gets Australian Approval, CE-IVD Mark for Multiplex Respiratory Virus Test

Industry news | 07 April, 2022 | CACLP

Original from: 360DX


Seegene said on Wednesday that it has received Australian approval and CE-IVD marking for its Allplex RV Master Assay for respiratory viruses.


The multiplex real-time PCR test is designed to detect molecular targets for 19 respiratory viruses including SARS-CoV-2, influenza, metapneumovirus, respiratory syncytial virus, adenovirus, and human rhinovirus.


Earlier this year, Seegene received approval under Health Canada's Interim Order for its Allplex SARS-CoV-2/FluA/FluB/RSV Assay. The South Korean company also recently obtained the CE-IVD mark for the Allplex SARS-CoV-2 fast MDx Assay.


Source: Seegene Gets Australian Approval, CE-IVD Mark for Multiplex Respiratory Virus Test

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference